An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. [electronic resource]
Producer: 20000608Description: 105-11 p. digitalISSN:- 0010-7824
- Adolescent
- Adult
- Androstenes -- adverse effects
- Blood Pressure
- Body Weight
- Contraceptives, Oral, Combined -- adverse effects
- Contraceptives, Oral, Hormonal -- adverse effects
- Ethinyl Estradiol -- adverse effects
- Female
- Humans
- Lipids -- blood
- Menstruation Disturbances -- chemically induced
- Mineralocorticoid Receptor Antagonists -- adverse effects
- Patient Compliance
- Progesterone Congeners -- adverse effects
- Surveys and Questionnaires
- Uterine Hemorrhage -- chemically induced
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.